Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Relevance of biomarkers across different neurodegenerative diseases
Alexander J. Ehrenberg, Ayesha Khatun, Emma M. Coomans, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain
Joseph R. Winer, Bryce A. Mander, Randolph F. Helfrich, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 32, pp. 6315-6324
Open Access | Times Cited: 200
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration
Nicholas J. Ashton, Antoine Leuzy, Yau Mun Lim, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 152
Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
John Robinson, Sharon X. Xie, Daniel R. Baer, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2557-2569
Open Access | Times Cited: 67
Modern Methods of Diagnostics and Treatment of Neurodegenerative Diseases and Depression
Natalia Shusharina, Denis Yukhnenko, Stepan Botman, et al.
Diagnostics (2023) Vol. 13, Iss. 3, pp. 573-573
Open Access | Times Cited: 56
Protein misfolding and amyloid nucleation through liquid–liquid phase separation
S. Mukherjee, Manisha Poudyal, K. Dave, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4976-5013
Closed Access | Times Cited: 25
The Evolution of Neurofilament Light Chain in Multiple Sclerosis
Carolina Ferreira‐Atuesta, Saúl Reyes, Gavin Giovanonni, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 101
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Christopher Clark, Piotr Lewczuk, Johannes Kornhuber, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 63
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Giulia Gentile, Giovanna Morello, Valentina La Cognata, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 770-770
Open Access | Times Cited: 48
Fractal dimension of the brain in neurodegenerative disease and dementia: A systematic review
Elina T Ziukelis, Elijah Mak, Maria‐Eleni Dounavi, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101651-101651
Open Access | Times Cited: 40
Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases
Adithya Anilkumar, Puneet Vij, Samantha Lopez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2268-2268
Open Access | Times Cited: 16
Electrochemical Biosensor for Point-of-Care Testing of Low-Abundance Biomarkers of Neurological Diseases
Ziyue Huang, Lei Zhang, Yanzhi Dou, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 25, pp. 10332-10340
Closed Access | Times Cited: 10
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation
Pradeepraj Durairaj, Zixiang Liu
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 44-44
Open Access | Times Cited: 1
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome
Paula Araya, Kohl T. Kinning, Christina Coughlan, et al.
Cell Reports (2022) Vol. 41, Iss. 13, pp. 111883-111883
Open Access | Times Cited: 31
A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease
Katherine W. Turk, Alexandra Geada, Victor E. Alvarez, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Application of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future
Di Hu, Yating Jin, Xiangqi Hou, et al.
Marine Drugs (2023) Vol. 21, Iss. 1, pp. 43-43
Open Access | Times Cited: 21
Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
Lourdes Álvarez‐Sánchez, Carmen Peña‐Bautista, Laura Ferré‐González, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1226-1226
Open Access | Times Cited: 20
Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: A multicenter cohort study
Yi Chen, Yunyun Wang, Qing‐Qing Tao, et al.
Clinica Chimica Acta (2024) Vol. 558, pp. 118784-118784
Open Access | Times Cited: 7
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer’s and Parkinson’s Diseases
Razieh Amini, Shadi Moradi, Rezvan Najafi, et al.
Oxidative Medicine and Cellular Longevity (2024) Vol. 2024, pp. 1-13
Open Access | Times Cited: 6
Quantification of Neurological Blood-Based Biomarkers in Critically Ill Patients With Coronavirus Disease 2019
Jennifer Cooper, Sophie Stukas, Ryan L. Hoiland, et al.
Critical Care Explorations (2020) Vol. 2, Iss. 10, pp. e0238-e0238
Open Access | Times Cited: 46
Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future
Münteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürk
Journal of Pharmaceutical and Biomedical Analysis (2021) Vol. 209, pp. 114479-114479
Closed Access | Times Cited: 38
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
Rita Azevedo, Chloé Jacquemin, Nicolas Villain, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1279-1279
Open Access | Times Cited: 26
Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect
Inês Ferreira, Amélia P. Rauter, Narcisa M. Bandarra
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 662-662
Open Access | Times Cited: 24
Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers
Sandra I. Anjo, Zhicheng He, Zohaib Hussain, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 681-681
Open Access | Times Cited: 5
Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease
Anett Hudák, Annamária Letoha, Csaba Vízler, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3407-3407
Open Access | Times Cited: 20
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
Gabriela Kocurova, Jan Říčný, Saak V. Ovsepian
Theranostics (2022) Vol. 12, Iss. 7, pp. 3045-3056
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top